Octave Announces Publication of Analytical Validation Study Results in Nature Communications More

Octave at the American Academy of Neurology 2024 Annual Meeting

Monday, April 15 – Thursday, April 18
Denver, Colorado

We had a fantastic time engaging with leading experts in neurology at the 2024 AAN Annual Meeting, where we had the opportunity to present our innovative approach to revolutionizing care in neurodegenerative diseases.

Octave at AAN 2024, Wrapped

Oral Presentation by Ferhan Qureshi

Our Senior Vice President of Biomarker R&D, Ferhan Qureshi, presented Octave’s findings on Optic Neuritis (ON), a common manifestation in multiple sclerosis (MS) that can substantially affect patients’ quality of life. 

Check out his full presentation here:

E-Poster Presentation

Check out our collaborative E-Poster: